These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 22049417)

  • 1. Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction.
    Morelli E; Moore H; Rebello TJ; Gray N; Steele K; Esposito E; Gingrich JA; Ansorge MS
    J Neurosci; 2011 Nov; 31(44):15742-50. PubMed ID: 22049417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reuptake of L-DOPA-derived extracellular dopamine in the striatum with dopaminergic denervation via serotonin transporters.
    Kannari K; Shen H; Arai A; Tomiyama M; Baba M
    Neurosci Lett; 2006 Jul; 402(1-2):62-5. PubMed ID: 16626862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative.
    Zhou FC; Lesch KP; Murphy DL
    Brain Res; 2002 Jun; 942(1-2):109-19. PubMed ID: 12031859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of chronic fluoxetine on social isolation-induced changes on sucrose consumption, immobility behavior, and on serotonin and dopamine function in hippocampus and ventral striatum.
    Brenes JC; Fornaguera J
    Behav Brain Res; 2009 Mar; 198(1):199-205. PubMed ID: 19027796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust presynaptic serotonin 5-HT(1B) receptor inhibition of the striatonigral output and its sensitization by chronic fluoxetine treatment.
    Ding S; Li L; Zhou FM
    J Neurophysiol; 2015 May; 113(9):3397-409. PubMed ID: 25787955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats.
    Conti MM; Ostock CY; Lindenbach D; Goldenberg AA; Kampton E; Dell'isola R; Katzman AC; Bishop C
    Neuropharmacology; 2014 Feb; 77():1-8. PubMed ID: 24067924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual control of dopamine synthesis and release by presynaptic and postsynaptic dopamine D2 receptors.
    Anzalone A; Lizardi-Ortiz JE; Ramos M; De Mei C; Hopf FW; Iaccarino C; Halbout B; Jacobsen J; Kinoshita C; Welter M; Caron MG; Bonci A; Sulzer D; Borrelli E
    J Neurosci; 2012 Jun; 32(26):9023-34. PubMed ID: 22745501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT(2B) receptors are required for serotonin-selective antidepressant actions.
    Diaz SL; Doly S; Narboux-Nême N; Fernández S; Mazot P; Banas SM; Boutourlinsky K; Moutkine I; Belmer A; Roumier A; Maroteaux L
    Mol Psychiatry; 2012 Feb; 17(2):154-63. PubMed ID: 22158014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.
    O'Shea E; Esteban B; Camarero J; Green AR; Colado MI
    Neuropharmacology; 2001; 40(1):65-74. PubMed ID: 11077072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute administration of SCH 23390 on dopamine and serotonin turnover in major dopaminergic areas and mesencephalic raphe nuclei--comparison with ritanserin.
    Lappalainen J; Hietala J; Koulu M; Sjöholm B; Syvälahti E
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(6):861-72. PubMed ID: 1722342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
    Epperson CN; Jatlow PI; Czarkowski K; Anderson GM
    Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
    Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
    Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated exposure to the herbicide atrazine alters locomotor activity and the nigrostriatal dopaminergic system of the albino rat.
    Rodríguez VM; Limón-Pacheco JH; Mendoza-Trejo MS; González-Gallardo A; Hernández-Plata I; Giordano M
    Neurotoxicology; 2013 Jan; 34():82-94. PubMed ID: 23123945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated.
    Lucas G; De Deurwaerdère P; Porras G; Spampinato U
    Neuropharmacology; 2000 Aug; 39(11):1984-95. PubMed ID: 10963742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of selective serotonin reuptake inhibitors via 5-HT1A receptors on L-DOPA-induced rotational behavior in a hemiparkinsonian rat model.
    Inden M; Abe M; Minamino H; Takata K; Yoshimoto K; Tooyama I; Kitamura Y
    J Pharmacol Sci; 2012; 119(1):10-9. PubMed ID: 22510520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L; Deng M; Zhang S; Fang Y; Li L
    Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):685-90. PubMed ID: 24910244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin-2C antagonism augments the effect of citalopram on serotonin and dopamine levels in the ventral tegmental area and nucleus accumbens.
    Visser AK; Kleijn J; van Faassen MH; Dremencov E; Flik G; Kema IP; Den Boer JA; van Waarde A; Dierckx RA; Bosker FJ
    Neurochem Int; 2015 Feb; 81():10-5. PubMed ID: 25542858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT2C receptor blockade reverses SSRI-associated basal ganglia dysfunction and potentiates therapeutic efficacy.
    Demireva EY; Suri D; Morelli E; Mahadevia D; Chuhma N; Teixeira CM; Ziolkowski A; Hersh M; Fifer J; Bagchi S; Chemiakine A; Moore H; Gingrich JA; Balsam P; Rayport S; Ansorge MS
    Mol Psychiatry; 2020 Dec; 25(12):3304-3321. PubMed ID: 30120415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic L-DOPA-pretreatment of rats: an electrophysiological and biochemical study in the basal ganglia.
    Jackson DM; Walters JR; Miller LP
    Brain Res; 1982 Nov; 250(2):271-82. PubMed ID: 6129029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.